These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comments on the report of the EFNS task force on IFN-beta antibodies in multiple sclerosis. Freedman MS. Eur J Neurol; 2007 Jun; 14(6):e7; author reply e10-1. PubMed ID: 17539930 [No Abstract] [Full Text] [Related]
4. Neutralising antibodies against interferon beta in multiple sclerosis. Antonelli G. Lancet; 2004 Jan 10; 363(9403):168; author reply 168-9. PubMed ID: 14726180 [No Abstract] [Full Text] [Related]
5. A novel assay to detect low-titred antibodies to interferon beta in multiple sclerosis patients. Di Marco P, Pagnotti P, Bellomi F, De Vito G, Sessa E, Bagnato F, Scagnolari C, Bramanti P, Antonelli G. New Microbiol; 2006 Jan 10; 29(1):11-8. PubMed ID: 16608120 [Abstract] [Full Text] [Related]
12. Critical review: assessment of interferon-β immunogenicity in multiple sclerosis. Bendtzen K. J Interferon Cytokine Res; 2010 Oct 10; 30(10):759-66. PubMed ID: 20874253 [Abstract] [Full Text] [Related]
13. Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients. Jensen PE, Sellebjerg F, Søndergaard HB, Sørensen PS. Eur J Neurol; 2012 Oct 10; 19(10):1311-7. PubMed ID: 22564111 [Abstract] [Full Text] [Related]
14. Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis. Ravnborg M, Bendtzen K, Christensen O, Jensen PE, Hesse D, Tovey MG, Sørensen PS. Mult Scler; 2009 Mar 10; 15(3):323-8. PubMed ID: 19028832 [Abstract] [Full Text] [Related]
15. Multiple sclerosis: relating MxA transcription to anti-interferon-beta-neutralizing antibodies. Hoffmann LA, Krumbholz M, Faber H, Kuempfel T, Starck M, Pöllmann W, Meinl E, Hohlfeld R. Neurology; 2007 Mar 20; 68(12):958-9. PubMed ID: 17372138 [No Abstract] [Full Text] [Related]
18. Significance of neutralizing antibodies to interferon beta during treatment of multiple sclerosis: expert opinions based on the Proceedings of an International Consensus Conference. Hartung HP, Munschauer F, Schellekens H. Eur J Neurol; 2005 Aug 20; 12(8):588-601. PubMed ID: 16053466 [Abstract] [Full Text] [Related]
19. Management of neutralizing antibodies against beta-IFN in beta-IFN-treated multiple sclerosis patients. Pachner AR, Brady J, Steiner I, Narayan K. J Neurol; 2008 Nov 20; 255(11):1815-7. PubMed ID: 19031099 [No Abstract] [Full Text] [Related]